NCT02627144 2016-08-29Bevacizumab in Metastatic Renal CancerHoffmann-La RocheCompleted365 enrolled 9 charts
NCT00723710 2015-08-26Effect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600)Merck Sharp & Dohme LLCCompleted299 enrolled 5 charts